PLXP Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (12 bal. 2023 @ 23:00):

Stats
Šios dienos apimtis	50.38M
Vidutinė apimtis	4.86M
Rinkos kapitalizacija	2.53M
EPS	$0 ( 2023-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.223
ATR14	$0.0270 (469.57%)

Insider Trading

Date	Person	Action	Amount	type
2022-03-15	Giordano Natasha	Buy	4 100	Common Stock
2022-03-15	O'connor Rita M	Buy	3 700	Common Stock
2022-03-15	O'connor Rita M	Buy	10 000	Common Stock
2022-02-22	Valentino Michael J	Buy	80 000	Stock Option (right to buy)
2022-02-22	O'connor Rita M	Buy	110 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 94 transactions
Buy: 5 718 001 \| Sell: 1 856 163

Tūris Koreliacija

Ilgas: 0.18 (neutral)

Trumpas: -0.79 (moderate negative)

Signal:(38.252) Neutral

PLx Pharma Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ONCS	0.955
WISA	0.952
INSG	0.947
IMRX	0.943
PRTK	0.943
INVE	0.943
TOI	0.942
VERV	0.938
TIL	0.937
TFFP	0.935

10 Labiausiai neigiamai susiję koreliacijos
AGFS	-0.912
CCRC	-0.91
LRFC	-0.907
MNKD	-0.903
IBEX	-0.901
STAY	-0.896
LWAC	-0.894
NWFL	-0.892
HZNP	-0.889
SLGN	-0.887

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

PLx Pharma Inc Koreliacija - Valiuta/Žaliavos

0.64
( weak )

0.79
( moderate )

0.00
( neutral )

0.78
( moderate )

-0.13
( neutral )

-0.79
( moderate negative )

PLx Pharma Inc Finansinės ataskaitos

Annual	2021
Pajamos:	$8.21M
Bruto pelnas:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2021
Pajamos:	$8.21M
Bruto pelnas:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2020
Pajamos:	$30 430.00
Bruto pelnas:	$30.43 (0.10 %)
EPS:	$-1.740

FY	2019
Pajamos:	$565 464
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-2.30

Financial Reports:

No articles found.

PLx Pharma Inc

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.